Last reviewed · How we verify

NCT05344573

Optimizing Pulsatility During Cardiopulmonary Bypass

Recruiting now Last updated 21 November 2024
What this trial tests

trial in Endothelial Dysfunction in 66 participants. Currently enrolling.

Timeline
5 July 2022
Primary endpoint
1 December 2024
1 July 2025

Quick facts

Lead sponsorUniversity of Colorado, Denver
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment66
Start date5 July 2022
Primary completion1 December 2024
Estimated completion1 July 2025
Sites1 location across United States

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 50 to 70, any sex, with Endothelial Dysfunction or Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiopulmonary bypass during cardiac surgery provides blood flow to the body during surgery but has adverse effects on different organs. Blood flow during cardiopulmonary bypass may be pulsatile or non-pulsatile, which may impact normal organ function after surgery. The study will collect data on the type of cardiopulmonary bypass used during surgery and organ function to determine if there is an association between the type of bypass and organ function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endothelial Dysfunction

Currently open trials in the same condition.

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05344573.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing